Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
Background: The mechanisms of drug resistance of cancer have not been yet elucidated in details. Recently, the role of mast cells (MCs) in the development of drug resistance has been brought in the limelight. The aim of the study was to examine the morphological features of doxorubicin (DOX)-resista...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2018 |
| Main Authors: | Boroday, N.V., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2018
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/139246 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells / N.V. Boroday, V.F. Chekhun // Experimental Oncology. — 2018 — Т. 40, № 1. — С. 42-47. — Бібліогр.: 30 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)
by: Todor, I.N., et al.
Published: (2015)
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: I. N. Todor, et al.
Published: (2015)
by: I. N. Todor, et al.
Published: (2015)
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)
by: Lukyanova, N.Yu., et al.
Published: (2009)
Metalloproteins during development of Walker-256 carcinosarcoma resistant phenotype
by: V. F. Chekhun, et al.
Published: (2015)
by: V. F. Chekhun, et al.
Published: (2015)
Magnetic nanotherapy of animals with carcinosarcoma Walker-256
by: V. E. Orel, et al.
Published: (2014)
by: V. E. Orel, et al.
Published: (2014)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009)
by: Rusetskaya, N.V., et al.
Published: (2009)
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)
by: Rusetskaya, N.V., et al.
Published: (2011)
Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth
by: Sarnatskaya, V.V., et al.
Published: (2023)
by: Sarnatskaya, V.V., et al.
Published: (2023)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma
by: Lozovska, Yu.V., et al.
Published: (2023)
by: Lozovska, Yu.V., et al.
Published: (2023)
Proinflammatory effects of photoactivated methylene blue on rat model of Walker 256 carcinosarcoma
by: Petrellis, M.C., et al.
Published: (2023)
by: Petrellis, M.C., et al.
Published: (2023)
Change of morphostructural characteristics and metabolic profile of Walker-256 carcinosarcoma under the impact of exogenous lactoferrin
by: L. A. Nalieskina, et al.
Published: (2020)
by: L. A. Nalieskina, et al.
Published: (2020)
Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model
by: Zykova, M.G., et al.
Published: (2012)
by: Zykova, M.G., et al.
Published: (2012)
Photodynamic responsiveness of human leukemia Jurkat/A4 cells with multidrug resistant phenotype
by: Philchenkov, A.A., et al.
Published: (2014)
by: Philchenkov, A.A., et al.
Published: (2014)
Combination of cyclooxygenase-2 inhibitor and doxorubicin increases the growth inhibition and apoptosis in human hepatocellular carcinoma cells
by: Pan, Y.Y., et al.
Published: (2007)
by: Pan, Y.Y., et al.
Published: (2007)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
by: Yurchenko, O.V., et al.
Published: (2010)
by: Yurchenko, O.V., et al.
Published: (2010)
Endometrial stromal cells: isolation, expansion, morphological and functional properties
by: Zlatska, A.V., et al.
Published: (2017)
by: Zlatska, A.V., et al.
Published: (2017)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Assessment of the effect of wave device application on morphological changes in organs and cells of irradiated animals
by: Bebeshko, V., et al.
Published: (2017)
by: Bebeshko, V., et al.
Published: (2017)
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)
by: Burlaka, A.P., et al.
Published: (2015)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Jurkat/A4 cells with multidrug resistance exhibit reduced sensitivity to quercetin
by: Philchenkov, A., et al.
Published: (2010)
by: Philchenkov, A., et al.
Published: (2010)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
by: Zadvornyi, T.V., et al.
Published: (2018)
by: Zadvornyi, T.V., et al.
Published: (2018)
Autogeneic RNA-electroporated CD40-ligand activated B-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo
by: Shen, S., et al.
Published: (2007)
by: Shen, S., et al.
Published: (2007)
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)
by: Chekhun, V.F., et al.
Published: (2014)
DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells
by: Svirnovski, A.I., et al.
Published: (2010)
by: Svirnovski, A.I., et al.
Published: (2010)
Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
by: Sviezhentseva, I.O., et al.
Published: (2015)
by: Sviezhentseva, I.O., et al.
Published: (2015)
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)
by: Lukyanova, N.Yu.
Published: (2010)
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)
by: Potebnya, G.P., et al.
Published: (2009)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Experimental validation of prevention of the development of stochastic effects of low doses of ionizing radiation based on the analysis of human lymphocytes’ chromosome aberrations
by: Domina, E.A., et al.
Published: (2013)
by: Domina, E.A., et al.
Published: (2013)
Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT resistant PC-3 and CPT-sensitive LNCaP cells
by: Mizutani, K., et al.
Published: (2006)
by: Mizutani, K., et al.
Published: (2006)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
The effect of cytostatics and hyperthermia on RAJI human lymphoma cells
by: Istomin, Yu.Р., et al.
Published: (2011)
by: Istomin, Yu.Р., et al.
Published: (2011)
Efects of PDT with 5-aminolevulinic acid and chitosan on Walker carcinosarcoma
by: Filip, A., et al.
Published: (2008)
by: Filip, A., et al.
Published: (2008)
Similar Items
-
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015) -
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: I. N. Todor, et al.
Published: (2015) -
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018) -
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009) -
Metalloproteins during development of Walker-256 carcinosarcoma resistant phenotype
by: V. F. Chekhun, et al.
Published: (2015)